Daikin Industries, Ltd.

Takeda Pharmaceutical Company Limited

Goodman Global Group, Inc.

Daikin Europe N.v.

Daikin Manufacturing Company, L.p.

Hideyuki Nakagawa

Satoshi Yamamoto

Junichi Shimoda

Masahiro Oka

Chris Bellshaw

Joseph Kelly Hearnsberger

Sriram Venkat

David Palazzolo

Hiroyuki Imada

Takashi Shimamura

Takahiro Yamada

Cheng Li

Shinichi Takahashi

Yuuji Yamada

John Clements

Masahiro Honda

Shinya Matsuoka

Junya Shirai

Yoshiyuki Fukase

Atsuko Ochida

Yoshihide Tomata

Ayumu Sato

Nobuyuki Matsunaga

Yoshihisa Nakada

Kazuko Yonemori

Yusuke Ohba

Akinori Nakai

A control system for a HVAC system for a structure and including a blower that flows air over an indoor heat exchanger. The control system may include a first input device, a first sensor, and a processor in electronic communication with the first input device, the first sensor, and the blower of the HVAC system. The first input device may be operable to accept a zoning mode selection. The first sensor may be sensor operable to measure a first temperature at a first location within the structure. The processor may be programmed to determine a cooling or heating demand on the HVAC system based on an input temperature and the first measured temperature. The processor may be further programmed to adjust an air flow rate produced by the blower based on the demand on the HVAC system and the zoning mode selection.

Control system for a heating, ventilation, and air-conditioning system

An HVAC system is provided. Embodiments of the present disclosure generally relate to an HVAC system in which multiple indoor units are coupled to central outdoor unit, where at least one of the indoor units is configured to provide conditioned air through ductwork and at least one indoor unit is configured to provide conditioned air without ductwork. Moreover, a gas furnace can be provided in the system, for harsher environments that benefit from more robust heating. Additional systems, devices, and methods are also disclosed.

System and method for heating and cooling

An air conditioning apparatus has a refrigerant circuit made up of plural indoor units connected to an outdoor unit, and the air conditioning apparatus has a capacity controlling part and a target refrigerant temperature mode setting part. The capacity controlling part controls the air conditioning capacity of the outdoor unit in such a way that the evaporation temperature of refrigerant in the refrigerant circuit becomes a target evaporation temperature, or in such a way that the condensation temperature of the refrigerant becomes a target condensation temperature. The target refrigerant temperature mode setting part is configured to seta target refrigerant temperature mode to either a target refrigerant temperature changing mode or a target refrigerant temperature fixing mode. The target refrigerant temperature changing mode changes the target evaporation temperature or the target condensation temperature, and the target refrigerant temperature fixing mode fixes the target evaporation temperature or the target condensation temperature.

Air conditioning apparatus

The present invention provides a fused heterocyclic compound having an ROR&#x3b3;t inhibitory action. The present invention relates to a compound represented by the formula (I'): wherein each symbol is as defined in the specification, provided that 2-(2-((4-cyanophenyl)amino)-2-oxoethoxy)-N-(9-ethyl-9H-carbazol-3-yl)acetamide and N-(4-cyanophenyl)-N&#x2032;-(9-ethyl-9H-carbazol-3-yl)-3-methylpentanediamide are excluded, or a thereof.

Condensed heterocyclic compound

The present invention aims to provide a compound having superior pharmacological action, physicochemical properties and the like and useful as an sGC activation drug, or an agent for the prophylaxis and/or treatment of diseases such as hypertension, ischemic cardiac disease, cardiac failure, kidney disease, arteriosclerotic disease, atrial fibrillation, pulmonary hypertension, diabetes, diabetic complications, metabolic syndrome, peripheral arterial obstruction, erectile dysfunction and the like. An sGC activation drug containing a compound represented by the formula (II): wherein each symbol is as defined in the specification, or a salt thereof, as an active ingredient.

Heterocyclic derivative and use thereof

Growing community of inventors

Osaka, Japan

Hideyuki Nakagawa